Bryce D. Carmine
2011
In 2011, Bryce D. Carmine earned a total compensation of $6.6M as Retired Executive Vice President and President, Lilly Bio-Medicines at Lilly Eli & Co, a 15% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,243,789 |
|---|---|
| Non-Equity Incentive Plan | $1,070,663 |
| Salary | $951,700 |
| Stock Awards | $2,250,000 |
| Other | $57,102 |
| Total | $6,573,254 |
Carmine received $2.3M in stock awards, accounting for 34% of the total pay in 2011.
Carmine also received $2.2M of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $951.7K in salary and $57.1K in other compensation.
Rankings
In 2011, Bryce D. Carmine's compensation ranked 728th out of 10,747 executives tracked by ExecPay. In other words, Carmine earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 728 out of 10,747 | 93rd |
Division Manufacturing | 261 out of 3,960 | 93rd |
Major group Chemicals And Allied Products | 61 out of 1,038 | 94th |
Industry group Drugs | 31 out of 786 | 96th |
Industry Pharmaceutical Preparations | 26 out of 571 | 95th |
Source: SEC filing on March 5, 2012.
Carmine's colleagues
We found five more compensation records of executives who worked with Bryce D. Carmine at Lilly Eli & Co in 2011.
2011
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2011
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2011
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2011
Robert Armitage
Lilly Eli & Co
General Counsel
2011
Enrique Conterno
Lilly Eli & Co